Soft Tissue Allografts Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Global Soft Tissue Allografts Market By Soft Tissue Allografts Type (Cartilage Allografts, Dental Allografts, Tendon Allografts, Amniotic Allograft, Collagen Allograft, and Meniscus Allografts), By Application (Wound Care, Dentistry, and Orthopedic), By End User (Hospitals, Dental Clinics, Orthopedic Clinics, Ambulatory Surgical Centers), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global soft tissue allografts market size valued USD 3,027.23 million in 2020 and expected to reach USD 4,512.23 million by 2027, at a CAGR of 6.8% during the period of 2021-2027. Soft tissue allografts are the medical devices that act as an important substitute for the reconstruction of deficient ligaments, osteochondral defects that occur during knee surgery and torn menisci. The soft tissue allografts help obtaining a stable knee post-surgery. The reconstruction of the soft tissues using allografts reduces the surgical time and less donor tissue site morbidity.

Soft Tissue Allografts Market

MARKET SUMMARY
-
6.8% CAGR
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 6.8%
  • Largest Market– Europe
  • Fastest Growing Market– North-America

Soft Tissue Allografts Market

  • The report on global soft tissue allografts market gives historical, current and future market sizes (US$ Mn) based on type, application, end user and region.
  • soft tissue allografts market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Allergen, Plc.
  • Alliqua BioMedical, Inc.
  • Arthrex, Inc.
  • R. Bard, Inc.
  • Lattice Biologics Ltd.
Soft Tissue Allografts Market

Drivers And Restraints

Increase in the prevalence of degenerative joint diseases and chronic disorders such as diabetes are the key factor attributed for the growth of the soft tissue allografts market. The technological advancements and improving healthcare infrastructure are boosting the growth of the market. The mergers and acquisitions will help market vendors to tap ever growing market opportunities in the market. However, the high cost involved in the treatment procedure is hindering the growth of the soft tissue allografts market. The stringent government regulations are likely to hinder the growth of the market.


North-America got significant share

Soft Tissue Allografts Market

Geographically, global soft tissue allografts market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America market growth driven by increase in the prevalence of diabetic foot ulcers. The deep-rooted healthcare infrastructure is enhancing the growth of the market in this region. The technological advancements, higher adoption of the modern treatment options, and growing awareness among the patient pool is also adding fuel for the growth of the market in North America region. The Europe and Asia Pacific are falling next to that of North American region. The Asia Pacific is expected to show significant growth over the forecasted period owing to developing healthcare sector in the emerging countries such as India, China and ASEAN countries.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Notable Market Developments

  • In February 2017, Allergan plc has acquired LifeCell Corporation, a leading regenerative medicine company

Key

Key Features of the Report

Soft Tissue Allografts Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Allergen, Plc. (Ireland)
  • Alliqua BioMedical, Inc. (U.S)
  • Arthrex, Inc. (U.S)
  • R. Bard, Inc. (U.S)
  • Lattice Biologics Ltd. (U.S)
  • Zimmer Biomet (U.S)
  • Straumann Holding AG (Switzerland)
  • Alliqua BioMedical, Inc. (U.S)
  • MiMedix Group (U.S)

Description

The global soft tissue allografts market size valued USD 3,027.23 million in 2020 and expected to reach USD 4,512.23 million by 2027, at a CAGR of 6.8% during the period of 2021-2027. Soft tissue allografts are the medical devices that act as an important substitute for the reconstruction of deficient ligaments, osteochondral defects that occur during knee surgery and torn menisci. The soft tissue allografts help obtaining a stable knee post-surgery. The reconstruction of the soft tissues using allografts reduces the surgical time and less donor tissue site morbidity.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX